Immunohistochemical analysis of IGF1R levels in breast tumor specimens derived from BRCA1/BRCA2 mutation carriers, compared to matched sporadic breast cancer patients, revealed higher IGF1R levels in tumors of BRCA mutation carriers (99). Here, IGF1R is linked to breast neoplasm.